ArticleParticle and fibre toxicology2025
Fiber length and shape-dependent differences in hepatic nanomaterial localization in mice following pulmonary exposure.
Article in Particle and fibre toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundInhaled nanomaterials can translocate from the lungs into systemic circulation and reach the liver, which is the main secondary organ for nanomaterial uptake, potentially causing adverse effects. Understanding how inhaled nanomaterials localize within liver tissue is important for understanding their clearance mechanisms and potential toxicity. Previous in vivo studies have primarily focused on spherical particles, highlighting the need for studies on fiber-shaped nanomaterials.
methodsThis study examines the hepatic distribution of five fiber-shaped nanomaterials (three multiwalled carbon nanotubes, gallium phosphide nanowires, and short TiO₂ nanotubes) compared to spherical TiO₂ nanoparticles. Liver samples were collected at 1, 3, 6, and 12 months after pulmonary exposure using a single intratracheal (IT) instillation in mice. Paraffin-embedded liver sections were stained with Hematoxylin and Eosin (H&E), and analyzed using enhanced darkfield microscopy. The localization of the nanomaterials within sections was categorized into four categories: hepatocyte, non-parenchymal cell, sinusoid/vessel, and another placement. Localization was further validated using cell-specific immunohistochemical staining. Furthermore, morphological changes were assessed in liver sections and 1 year post-exposure from mice following pulmonary exposure to eleven different MWCNTs.
resultsThe hepatic localization of six different nanomaterials were assessed, with more than 10,000 fibers or particles manually counted across all samples. There were significant differences in the localization of long and thick fibers as compared to spherical nanoparticles and short and thin fibers, at all assessed post-exposure time points. Long and thick fiber-shaped nanomaterials were more frequently localized within the liver parenchyma compared to spherical particles and the short TiO
conclusionThese findings demonstrate that the intrahepatic localization of nanomaterials is strongly influenced by fiber shape and dimensions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.